DIPNA PHARMACHEM Q1 : STANDALONE NET PROFIT DOWN 30.9% AT ₹39.42 L (YOY), UP 120.7% (QOQ). MIX (On 1st Look)

Revenue up 9.9% at ₹20.33 Cr (YOY), up 904% (QOQ). Total income up 28.6% at ₹23.79 Cr (YOY), up 1,060% (QOQ). Ebitda up 13.4% at ₹83.37 L (YOY); margins 4.10% v 3.97% (YOY), 22.65% (QOQ). Finance costs up 90.2% at ₹30.54 L (YOY).

Dipna Pharmachem Ltd

Open attachment

← Back to feed